MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by mrmarket1on Oct 27, 2022 2:30pm

189 Views

Post# 35053882

medmira said 9 months ago

MedMira's Reveal® G4 HIV test, previously approved by the FDA/PMA, has begun the clinical trials required to complete the final phase of regulatory work and receive FDA CLIA listing. This new claim gives the company access to a market of over $350 million per year in the United States that includes physician offices, clinics and other healthcare providers.
The Company will report regularly on its progress and intends
to complete this within the first two quarters,

barring COVID-19 restrictions.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals